Phase I trial of daily subcutaneous SPL-108 injections in combination with paclitaxel in patients with platinum resistant CD44+ advanced ovarian epithelial cancer
每日皮下注射 SPL-108 联合紫杉醇治疗铂类耐药 CD44+ 晚期卵巢上皮癌患者的 I 期临床试验
期刊:International Journal of Gynecological Cancer
影响因子:4.1
doi:10.1136/ijgc-2021-003316
Eugenia Girda, June Hou, David Nelson, Malcolm Finlayson, Alexandre Buckley de Meritens, Marina Chekmareiva, Aliza Leiser, Mihae Song, Ruth Stephenson, Nancy Chan, Ana I Tergas, Reena Vattakalam, Jason D Wright, Hua Yu, Antons Martincuks, Adrian Kohut, Joycelynne Palmer, Lorna Rodriguez-Rodriguez
